Heroin and Prescription Opioid Abuse Prevention, Education,
and Enforcement Act of 2015
Introduced on 6-17-15 by Susan Brooks [R-IN-5] and referred to the Committees on Energy and Commerce and Judiciary, then to the Subcommittee on Crime, Terrorism, Homeland Security and Investigations. Cosponsored by Joseph Kennedy III [D-MA-4], Andre Carson [D-IN-7], Jackie Walorski [R-IN-2], Ed Whitfield [R-KY-1], Luke Messer [R-IN-6], Ann Kuster [D-NH-2], Frank Guinta [R-NH-1], Todd Young [R-IN-9], Barbara Comstock [R-VA-10], John Carney [D-DE-At Large], Kathleen Rice [D-NY-4], Derek Kilmer [D-WA-6], John Katko [R-NY-24], Katherine Clark [D-MA-5], Andy Barr [R-KY-6], Lou Barletta [R-PA-11], Elise Stefanik [R-NY-21], Sean Patrick Malony [D-NY-18], Elizabeth Esty [D-CT-5], James McGovern [D-MA-2], Steve Stivers [R-OH-15], Tim Ryan [D-OH-13], Tim Walberg [R-MI-7], Scott Peters [D- CA-52], Ryan Costello, [R-PA-6], Eric Swalwell [D-CA-15], Charles Dent [R-PA-15], Ben Lujan [D-NM-3], Mimi Walters [R-CA-45], William Keating [D-MA-9], Keith Rothfus [R-PA-12], Robert Dold [R-IL-10], Sander Levin [D-MI-9]l, James Renacci [R-OH-16], Greg Walden [R-OR-2], Brad Wenstrup [R-OH-2], Doris Matsui [D-CA-6], Rodney Davis [R-IL-13], Steve Chabot [R-OH-1], Seth Moulton [D-MA-6], Darin LaHood [R-IL-18], Scott Tipton [R-CO-3], and Marcy Kaptur [D-OH-9]. Related Bills are H.R.1725 and S.1134.
Purpose: To address prescription opioid abuse and heroin use.
SEC. 2. Findings.
Congress makes the following findings:
(1) Many controlled substances have a useful and legitimate medical purpose and are necessary to maintain the health and general welfare of the people of the United States.
(2) Pain is a major national health problem and treatment is a high priority.
(3) Prescription opioids are susceptible to diversion and abuse.
(4) Compares heroin and prescription drugs and the availability and statistics of heroin use.
(5) The Edward Byrne Memorial Justice Assistance Grant Program under part E of title I of the Omnibus Crime Control and Safe Streets Act of 1968 (42 U.S.C. 3750 et seq.) is critical to fighting the prescription opioid abuse and heroin use epidemics, and should be reauthorized and fully funded.
SEC. 3. Development of best prescribing practices.
(a) Forms an Inter-Agency task force comprised of representatives of DHHS, VA, DoD, DEA, the Office of National Drug Control Policy, the Institute of Medicine, the Director of the National Institutes of Health, practitioners, pharmacists; experts in pain and addiction research, pain management professional organizations, the mental health treatment community, the addiction treatment community, pain advocacy groups, a person in recovery from addiction to medication for chronic pain, a person with chronic pain; and other stakeholders.
(1) develop best practices for pain management and prescribing, taking into consideration existing pain management research, recommendations from relevant conferences; ongoing efforts to develop improved pain management strategies, public comment
(2) develop a strategy for disseminating information about the best practices developed to prescribers, pharmacists, State medical boards, educational institutions and other parties
The task force shall not have rulemaking authority. It shall submit a report to Congress.
SEC. 4. Amendments to controlled substance monitoring program to include maintenance of already established programs.
SEC. 5. Reauthorization of Byrne justice assistance grant program through 2020.
SEC. 6. Awareness campaigns.
(a) The Secretary of hhs shall advance the education and awareness of the public, providers, and patients, of the risk of abuse of prescription opioid drugs.
(b) Drug-Free media campaign.—The Office of National Drug Control Policy, in coordination with the Secretary of HHS and the Attorney General, shall establish a national drug awareness campaign which shall:
(1) take into account the association between prescription opioid abuse and heroin use;
(2) emphasize the similarities between heroin and prescription opioids and their effects on the body;
(3) bring greater public awareness to the dangerous effects of fentanyl when mixed with heroin or abused in a similar manner.
(c) Funds for the national drug awareness campaign may be derived from amounts appropriated to the Office of National Drug Control Policy.
SEC. 7. Naloxone demonstration grants.
(b) Authorizes grants to create 8 3-year demonstration programs for emergency personnel to administer an opioid overdose reversal drug to an individual who has experienced overdose.
(g) Evaluation.—recipients shall report to the Attorney General on an annual basis and the AG will report to Congress.
SEC. 8. Offset.
The amounts expended to carry out this Act should be offset by a corresponding reduction in Federal non-defense discretionary spending.